Call for Liberal minister to resign over campaign texts Pressure is mounting on a state minister over her knowledge and public comments relating to promotional messages sent during an election campaign. AAP · Jun 15
'Confident' London drivers are far more likely to crash on country roads, study finds Londoners are significantly more likely to crash on rural roads compared to others, a new study has found Evening Standard · Dec 8, 2025
DOGE wanted to assign staff to the nonprofit Vera Institute of Justice because it got federal funds The nonprofit Vera Institute of Justice says staff from Elon Musk’s DOGE contacted them to “assign” a team to the organization and said DOGE staff told them they intended to “assign” teams to all nonprofits that receive funds appropriated by Congress The Independent UK · Apr 16, 2025
Three-drug therapy ‘doubles breast cancer survival time without progression’ The trial included 325 patients from across 28 countries. Evening Standard · Oct 30, 2024
Meet the man who has been helping to build Glastonbury Festival for decades Joe Rush has been the festival's key artistic collaborator for decades Bristol Post · May 13, 2023
Farmers still grappling with impact of 2022 NSW flood crisis optimistic about winter crop Recent rain gives the farming sector hope for a successful winter crop, after a challenging six months following last year's devastating flooding. ABC News · Apr 29, 2023
Could climate change turn North-West Tasmania into a wine destination? These growers are 'optimistic' Step aside Yarra Valley and Coonawarra, Tassie's traditional dairy and potato heartland is muscling in on the wine scene — with a little help from climate change. ABC News · Apr 28, 2023
A crime bill was supposed to fix Washington DC’s problems. Instead, it polarized a city The new code revised 120-year-old criminal laws, but the effort was stymied by Joe Biden and an unlikely alliance of Republicans and Democrats The Guardian - US · Mar 12, 2023
Aptamer: the York biotech working on precision cancer treatments UK firm links with up global drug firms to make synthetic antibodies capable of binding to targets such as tumour cells The Guardian - UK · Dec 25, 2022
Scientists hail ‘landmark moment’ in the treatment of advanced breast cancer Capivasertib is being made by pharmaceutical giant AstraZeneca following a programme of drug discovery research at the Institute of Cancer Research. The Independent UK · Dec 8, 2022
‘Landmark moment’ in breast cancer treatment could save thousands of lives each year ‘The treatment is far less debilitating than chemotherapy and I’ve been given the gift of a longer life,’ says one patient The Independent UK · Dec 8, 2022
Tributes to former boss of popular Nottingham bar who's described as a 'legend' He believed 'everyone had to start somewhere' Nottingham Post · Mar 22, 2022